Page last updated: 2024-09-02

valerates and ridogrel

valerates has been researched along with ridogrel in 8 studies

Compound Research Comparison

Studies
(valerates)
Trials
(valerates)
Recent Studies (post-2010)
(valerates)
Studies
(ridogrel)
Trials
(ridogrel)
Recent Studies (post-2010) (ridogrel)
2,25129445790101

Protein Interaction Comparison

ProteinTaxonomyvalerates (IC50)ridogrel (IC50)
Thromboxane A2 receptor Homo sapiens (human)2.48
Thromboxane-A synthase Homo sapiens (human)0.0062
Thromboxane-A synthaseRattus norvegicus (Norway rat)0.006

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19906 (75.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banić, A; Kouris, K; Nazal, M; Rajacić, N; Thulesius, O1
Arnout, J; De Reys, S; Deckmyn, H; Falcon, C; Hoet, B; Vermylen, J1
Beetens, J; De Clerck, F; Janssen, PA; Van de Water, A; Vercammen, E1
Beetens, J; de Chaffoy de Courcelles, D; De Clerck, F; Freyne, E; Janssen, PA; Vercammen, E1
Aoki, N; Johnson, G; Lefer, AM; Siegfried, MR1
Beetens, J; de Chaffoy de Courcelles, D; De Clerck, F; Freyne, E; Janssen, PA1
Arnout, J; Hoet, B; Vermylen, J1
Lumley, P; Watts, IS; Wharton, KA; White, BP1

Trials

2 trial(s) available for valerates and ridogrel

ArticleYear
R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.
    Blood, 1990, Feb-01, Volume: 75, Issue:3

    Topics: Aspirin; Bleeding Time; Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Double-Blind Method; Humans; In Vitro Techniques; Pentanoic Acids; Phosphoproteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase; Valerates

1990
R68070, a combined thromboxane/endoperoxide receptor antagonist (TRA) and thromboxane synthase inhibitor (TSI), prolongs the bleeding time more than aspirin in man.
    Progress in clinical and biological research, 1989, Volume: 301

    Topics: Aspirin; Bleeding Time; Blood Platelets; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Humans; In Vitro Techniques; Male; Pentanoic Acids; Prostaglandins; Pyridines; Random Allocation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase; Valerates

1989

Other Studies

6 other study(ies) available for valerates and ridogrel

ArticleYear
Increased skin flap viability after treatment with forskolin or with ridogrel, a thromboxane synthesis inhibitor and receptor blocker.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1990, Volume: 190, Issue:3

    Topics: Animals; Colforsin; Graft Survival; Male; Microcirculation; Pentanoic Acids; Pyridines; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Skin; Surgical Flaps; Thromboxane A2; Valerates

1990
R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.
    Thrombosis and haemostasis, 1989, Feb-28, Volume: 61, Issue:1

    Topics: Adult; Animals; Arrhythmias, Cardiac; Blood Coagulation; Coronary Thrombosis; Dogs; Fibrinolysis; Hemostasis; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Reperfusion Injury; Pentanoic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase; Valerates

1989
R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
    Progress in clinical and biological research, 1989, Volume: 301

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Humans; In Vitro Techniques; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides; Pyridines; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase; Valerates

1989
Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Eicosanoids, 1989, Volume: 2, Issue:3

    Topics: Animals; Cathepsin D; Male; Myocardial Depressant Factor; Pentanoic Acids; Pyridines; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Shock, Traumatic; Thromboxane A2; Thromboxane-A Synthase; Valerates

1989
R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    Thrombosis and haemostasis, 1989, Feb-28, Volume: 61, Issue:1

    Topics: Animals; Arachidonic Acids; Blood Platelets; Cyclic AMP; Humans; In Vitro Techniques; Pentanoic Acids; Phosphatidylinositols; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Pyridines; Rabbits; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Sheep; Thromboxane B2; Thromboxane-A Synthase; Valerates

1989
Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivo.
    British journal of pharmacology, 1989, Volume: 98 Suppl

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Biphenyl Compounds; Collagen; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; In Vitro Techniques; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyridines; Thromboxane-A Synthase; Valerates

1989